Evolent Health, Inc.

Aug 19, 2025

Evolent Health, Inc. Announces Pricing of Oversubscribed and Upsized $145.0 Million of Convertible Senior Notes Due 2031 to Repurchase Existing Notes and Class A Common Stock

Aug 07, 2025

Evolent Announces Second Quarter 2025 Results

Apr 15, 2025

Evolent program achieves 20% reduction in use of low-value oncology regimens

May 09, 2024

Evolent and Careology form strategic care navigation partnership to enhance cancer care in the U.S.

Jan 25, 2024

Evolent to Release Fourth Quarter 2023 Financial Results on Thursday, February 22, 2024